Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma

Journal of Infectious Diseases

Volumn 187, Issue 8, 2003, Pages 1165-1177

  Semino Mora, Cristina ^a   Doi, Sonia Q ^b   Marty, Aileen ^a   Simko, Vlado ^c   Carlstedt, Ingemar ^d   Dubois, Andre ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Uniformed Services University of the Health Sciences   (United States)

^c Vet Admin NY Harbor Hlthcare S   (United States)

^d LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BABA2 PROTEIN; CAGA PROTEIN; MESSENGER RNA; MUCIN 2; RNA 16S; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

AGED; ARTICLE; BACTERIAL VIRULENCE; CARCINOGENESIS; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; OLIGONUCLEOTIDE PROBE; PRECANCER; PRIORITY JOURNAL; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH EPITHELIUM; TRANSMISSION ELECTRON MICROSCOPY;

ADENOCARCINOMA; ADHESINS, BACTERIAL; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CARRIER PROTEINS; COLONY COUNT, MICROBIAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; RNA, BACTERIAL; STOMACH; STOMACH NEOPLASMS; VIRULENCE;

EID: 0345269172     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368133     Document Type: Article

References (66)

1. Anonymous. IARC Monograph on the evaluation of carcinogenic risks to humans: schistosomes, liver flukes and Helicobacter pylori. Lyon, France: International Agency for Research on Cancer, 1994.
2. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prey 1997; 6:639-42.
3. Hdicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49:347-53.
4. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-5.
5. Censini S, Lange C, Xiang Z, et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci USA 1996; 93:14648-53.
6. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40:297-301.
7. Ilver D, Arnqvist A, Ogren J, et al. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 1998; 279:373-7.
8. Gerhard M, Lehn N, Neumayer N, et al. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci USA 1999; 96:12778-83.
9. Haenszel W, Correa P. Developments in the epidemiology of stomach cancer over the past decade. Cancer Res 1975; 35:3452-9.
10. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995; 19(Suppl 1):S37-43.
11. Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN. Subtypes of intestinal metaplasia and Helicobacter pylori. Gut 1992; 33:597-600.
12. Sakaki N. Helicobacter pylori and gastric cancer in view of relation to atrophy of background gastric mucosa [in Japanese]. Nippon Rinsho 1993; 51:3242-7.
13. Fukuda H, Saito D, Hayashi S, et al. Helicobacter pylori infection, serum pepsinogen level, and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 1995; 86:64-71.
14. Genta RM, Robason GO, Graham DY. Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol 1994; 25:221-6.
15. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161-81.
16. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993; 61:1799-809.
17. Mitsuuchi M, Hinoda Y, Itoh F, et al. Expression of MUC2 gene in gastric regenerative, metaplastic and neoplastic epithelia. J Clin Lab Anal 1999; 13:259-65.
18. Wilkinson DG. In situ hybridization: a practical approach. Oxford: Oxford University Press, 1998.
19. Jaju R, Haas OA, Neat M, et al. A new recurrent translocation, t(5;11)(q35;p15.5), associated with del(5q) in childhood acute myeloid leukemia. The UK Cancer Cytogenetics Group (UKCCG). Blood 1999; 94:773-80.
20. Lan Z-D, Dai L, Zhuo X-L, Feng J-C, Xu K, Chi CW. Gene cloning and sequencing of BmK AS and BmK AS-1, two novel neurotoxins from the scorpion Butus martensi Karsch. Toxicon 1999; 37:815-23.
21. Herrmann A, Davies JR, Lindell G, et al. Studies on the "insoluble" glycoprotein complex from human colon: identification of reduction-insensitive MUC2 oligomers and C-terminal cleavage. J Biol Chem 1999; 274:15828-36.
22. Hovenberg HW, Davies JR, Carlstedt I. Different mucins are produced by the surface epithelium and the submucosa in human trachea: identification of MUC5AC as a major mucin from the goblet cells. Biochem J 1996; 318:319-24.
23. Bravo JC, Correa P. Sulphomucins favour adhesion of Helicobacter pylori to metaplastic gastric mucosa. J Clin Pathol 1999; 52:137-40.
24. Semino-Mora MC, Leon-Monzon M, Dalakas MC. The effect of L-carnitine on the AZT-induced destruction of human myotubes. I. L-carnitine prevents the myotoxicity of AZT in vitro. Lab Invest 1994; 71:102-12.
25. Semino-Mora C, Dalakas MC. Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis. Hum Pathol 1998; 29:1128-33.
26. Dalakas MC, Semino-Mora C, Leon-Monzon M. Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2′3′-dideoxycytidine (ddC). Lab Invest 2001; 81:1537-44.
27. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000; 92:1881-8.
28. Segal ED, Falkow S, Tompkins LS. Helicobacter pylori attachment to gastric cells induces cytoskeletal rearrangements and tyrosine phosphorylation of host cell proteins. Proc Natl Acad Sci USA 1996; 93:1259-64.
29. Dawson PA, Filipe MI. An ultrastructural and histochemical study of the mucous membrane adjacent to and remote from carcinoma of the colon. Cancer 1976; 37:2388-98.
30. Worku ML, Sidebotham RL, Walker MM, Keshavarz T, Karim QN. The relationship between Helicobacter pylori motility, morphology and phase of growth: implications for gastric colonization and pathology. Microbiology 1999; 145:2803-11.
31. Andersen LP, Holck S. Possible evidence of invasiveness of Helicobacter (Campylobacter) pylori. Eur J Clin Microbiol Infect Dis 1990; 9:135-8.
32. Wyle FA, Tarnawski A, Schulman D, Dabros W. Evidence for gastric mucosal cell invasion by (2. pylori: an ultrastructural study. J Clin Gastroenterol 1990; 12:S92-8.
33. Evans DG, Evans DJ, Graham DY. Adherence and internalization of Helicobacter pylori by HEp-2 cells. Gastroenterology 1992; 102:1557-67.
34. Dubois A, Fiala N, Heman-Ackah LM, et al. Natural gastric infection with Helicobacter pylori in monkeys: a model for human infection with spiral bacteria. Gastroenterology 1994; 106:1405-17.
35. Engstrand L, Graham D, Scheynius A, Genta RM, El Zaatari F. Is the sanctuary where Helicobacter pylori avoids antibacterial treatment intracellular? Am J Clin Pathol 1997; 108:504-9.
36. Ko GH, Kang SM, Kim YK et al. Invasiveness of Helicobacter pylori into human gastric mucosa. Helicobacter 1999; 4:77-81.
37. Genta RM. Helicobacter pylori as a promoter of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur J Gastroenterol Hepatol 1995; 7(Suppl 1):S25-30.
38. Genta RM, Gurer IE, Graham DY, et al. Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. Gastroenterology 1996; 111:1206-11.
39. Karttunen TJ, Genta RM, Yoffe B, Hachem CY, Graham DY, El-Zaatari FA. Detection of Helicobacter pylori in paraffin-embedded gastric biopsy specimens by in situ hybridization. Am J Clin Pathol 1996; 106:305-311.
40. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci USA 1999; 96:14559-64.
41. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci USA 2000; 97:1263-8.
42. Meyer-ter-Vehn T, Covacci A, Kist M, Pahl HL. Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem 2000; 275:16064-72.
43. Ekström AM, Held M, Hansson LE, Engstrand L, Nyrén O. The role of Helicobacter pylori in gastric cancer revised: CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121:784-91.
44. Björkholm B, Lundin A, Sillén A, et al. Comparison of genetic divergence and fitness between two subclones of H. pylori. Infect Immun 2001; 69:7832-8.
45. Fantry GT, Zheng QX, Darwin PE, Rosenstein AH, James SP. Mixed infection with cagA-positive and cagA-negative strains of Helicobacter pylori. Helicobacter 1996; 1:98-106.
46. Figura N, Vindigni C, Covacci A, et al. cagA positive and negative Helicobacter pylori strains are simultaneously present in the stomach of most patients with non-ulcer dyspepsia: relevance to histological damage. Gut 1998; 42:772-8.
47. Noach LA, Rolf TM, Tytgat GN. Electron microscopic study of association between Helicobacter pylori and gastric and duodenal mucosa. J Clin Pathol 1994; 47:699-704.
48. el Shoura SM. Helicobacter pylori. I. Ultrastructural sequences of adherence, attachment, and penetration into the gastric mucosa. Ultrastruct Pathol 1995; 19:323-33.
49. Amieva MR, Salama N, Tompkins LS, Falkow S. Helicobacter pylori enter and survive within multivesicular vacuoles of epithelial cells. Cellular Microbiology 2002; 4:677-90.
50. Kwok T, Backert S, Schwarz H, Berger J, Meyer TF. Specific entry of Helicobacter pylori into cultured gastric epithelial cells via a zipper-like mechanism. Infect Immun 2002; 70:2108-20.
51. Boleti H, Benmerah A, Ojcius DM, Cerf-Bensussan N, Dautry-Varsat A. Chlamydia infection of epithelial cells expressing dynamin and Eps 15 mutants: clathrin-independent entry into cells and dynamin-dependent productive growth. J Cell Sci 1999; 112:1487-96.
52. Björkholm B, Zhukhovitsky V, Lofman C, et al. Helicobacter pylori entry into human gastric epithelial cells: a potential determinant of virulence, persistence, and treatment failures. Helicobacter 2000; 5:148-54.
53. Revell PA, Miller VL. A chromosomally encoded regulator is required for expression of the Yersinia enterocolitica inv gene and for virulence. Mol Microbiol 2000; 35:677-85.
54. Steele-Mortimer O, Brumell JH, Knodler LA, Meresse S, Lopez A, Finlay BB. The invasion-associated type III secretion system of Salmonella enterica serovar Typhimurium is necessary for intracellular proliferation and vacuole biogenesis in epithelial cells. Cell Microbiol 2002; 4:43-54.
55. Gay-wee J, Radulovic S, Higgins JA, Azad AF. Transcriptional analysis of Rickettsia prowazekii invasion gene homolog (invA) during host cell infection. Infect Immun 2002; 70:6346-54.
56. Tomb JF, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997; 388:539-47.
57. Reis CA, David L, Correa P, et al. Intestinal metaplasia of human stomach displays distinct patterns ofmucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 1999; 59:1003-7.
58. Ho SB, Shekels LL, Toribara NW, et al. Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res 1995; 55:2681-90.
59. Taylor KL, Mall AS, Barnard RA, Ho SB, Cruse JP. Immunohistochemical detection of gastric mucin in normal and disease states. Oncol Res 1998; 10:465-73.
60. Lopez-Ferrer A, de Bolos C, Barranco C, et al. Role of fucosyltransferases in the association between apomucin and Lewis antigen expression in normal and malignant gastric epithelium. Gut 2000; 47:349-56.
61. Lee HW, Ahn DH, Crawley SC, et al. Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-kappa B. J Biol Chem 2002; 277:32624-31.
62. Wessler S, Hocker M, Fischer W, et al. Helicobacter pylori activates the histidine decarboxylase promoter through a mitogen-activated protein kinase pathway independent of pathogenicity island-encoded virulence factors. J Biol Chem 2000; 275:3629-36.
63. Endoh Y, Tamura G, Motoyama T, Ajioka Y, Watanabe H. Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach. Hum Pathol 1999; 30:826-32.
64. Sung JJ, Lin SR, Ching JY, et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000; 119:7-14.
65. Dubois A, Semino-Mora MC, Woreta H, Doi S, Carlstedt I. H. pylori infection decreases expression of normal (MUC5AC) and increases expression of precancerous (MUC2) apomucins in non human primates. Gut 2001; 49:A47.
66. Ohkusa T, Fujiki K, Takashimizu I, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134:380-6.